Symplast Adds Mobile e-Prescribing to their Comprehensive Platform through DoseSpot™ Integration

Fort Lauderdale, FL – Symplast, the only mobile-first EHR/Practice Management platform that empowers plastic surgeons and patients, announced that it has completed Surescripts certification through DoseSpot and now offers robust mobile e-Prescription from the Symplast iOS app.
“As the only mobile-first, comprehensive platform for cash-primary plastic surgery, the ability to integrate with an app-friendly vendor like DoseSpot was a perfect fit,” said Facundo Formica, CEO/CTO, Symplast. “This mobile e-Prescription reinforces the paradigm shift Symplast continues to pioneer in aesthetics, addressing existing industry pain points through groundbreaking mobile technology.”
Through this partnership with DoseSpot, Symplast users are equipped to:
Safely and efficiently send prescriptions electronically to more than 65,000 pharmacies
Automatically check for dangerous drug-drug and drug-allergy interactions
Aggregate prescription history data from community pharmacies in addition to patient medication claims history from payers and pharmacy benefit managers
Request information on patient insurance eligibility and formulary at the time of prescribing
Prescribe Schedule II narcotics and receive a unique token
Save ‘Favorite’ prescription line items for future use
Mobile e-Prescription is now available for all Symplast users.